GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (OCSE:PEG) » Definitions » Equity-to-Asset

Pharma Equity Group A/S (OCSE:PEG) Equity-to-Asset : 0.41 (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Pharma Equity Group A/S Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Pharma Equity Group A/S's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr31.76 Mil. Pharma Equity Group A/S's Total Assets for the quarter that ended in Mar. 2024 was kr78.28 Mil.

The historical rank and industry rank for Pharma Equity Group A/S's Equity-to-Asset or its related term are showing as below:

OCSE:PEG' s Equity-to-Asset Range Over the Past 10 Years
Min: -1435.92   Med: 0.74   Max: 0.99
Current: 0.41

During the past 13 years, the highest Equity to Asset Ratio of Pharma Equity Group A/S was 0.99. The lowest was -1435.92. And the median was 0.74.

OCSE:PEG's Equity-to-Asset is ranked worse than
69.92% of 1556 companies
in the Biotechnology industry
Industry Median: 0.67 vs OCSE:PEG: 0.41

Pharma Equity Group A/S Equity-to-Asset Historical Data

The historical data trend for Pharma Equity Group A/S's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S Equity-to-Asset Chart

Pharma Equity Group A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.60 0.67 0.65 0.48

Pharma Equity Group A/S Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.65 0.62 0.48 0.41

Competitive Comparison of Pharma Equity Group A/S's Equity-to-Asset

For the Biotechnology subindustry, Pharma Equity Group A/S's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Equity Group A/S's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Equity Group A/S's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Pharma Equity Group A/S's Equity-to-Asset falls into.



Pharma Equity Group A/S Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Pharma Equity Group A/S's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=38.931/81.335
=

Pharma Equity Group A/S's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=31.76/78.281
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Equity Group A/S  (OCSE:PEG) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Pharma Equity Group A/S Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Equity Group A/S (OCSE:PEG) Business Description

Traded in Other Exchanges
N/A
Address
Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970
Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.